FR2976806B1 - Composition topique filmogene et son utilisation pour le traitement des mycoses - Google Patents

Composition topique filmogene et son utilisation pour le traitement des mycoses

Info

Publication number
FR2976806B1
FR2976806B1 FR1155492A FR1155492A FR2976806B1 FR 2976806 B1 FR2976806 B1 FR 2976806B1 FR 1155492 A FR1155492 A FR 1155492A FR 1155492 A FR1155492 A FR 1155492A FR 2976806 B1 FR2976806 B1 FR 2976806B1
Authority
FR
France
Prior art keywords
filmogenic
mycoses
treatment
topical composition
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1155492A
Other languages
English (en)
Other versions
FR2976806A1 (fr
Inventor
Claire Bouvier
Nathalie Derain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Urgo SAS
Original Assignee
Laboratoires Urgo SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Urgo SAS filed Critical Laboratoires Urgo SAS
Priority to FR1155492A priority Critical patent/FR2976806B1/fr
Priority to US14/128,114 priority patent/US20140128468A1/en
Priority to EP12731594.3A priority patent/EP2723326A1/fr
Priority to PCT/FR2012/051420 priority patent/WO2012175881A1/fr
Publication of FR2976806A1 publication Critical patent/FR2976806A1/fr
Application granted granted Critical
Publication of FR2976806B1 publication Critical patent/FR2976806B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1155492A 2011-06-22 2011-06-22 Composition topique filmogene et son utilisation pour le traitement des mycoses Expired - Fee Related FR2976806B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1155492A FR2976806B1 (fr) 2011-06-22 2011-06-22 Composition topique filmogene et son utilisation pour le traitement des mycoses
US14/128,114 US20140128468A1 (en) 2011-06-22 2012-06-21 Topical film-forming composition, and use thereof for treating mycoses
EP12731594.3A EP2723326A1 (fr) 2011-06-22 2012-06-21 Composition topique filmogène et son utilisation pour le traitement des mycoses
PCT/FR2012/051420 WO2012175881A1 (fr) 2011-06-22 2012-06-21 Composition topique filmogène et son utilisation pour le traitement des mycoses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1155492A FR2976806B1 (fr) 2011-06-22 2011-06-22 Composition topique filmogene et son utilisation pour le traitement des mycoses

Publications (2)

Publication Number Publication Date
FR2976806A1 FR2976806A1 (fr) 2012-12-28
FR2976806B1 true FR2976806B1 (fr) 2013-06-28

Family

ID=46456913

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1155492A Expired - Fee Related FR2976806B1 (fr) 2011-06-22 2011-06-22 Composition topique filmogene et son utilisation pour le traitement des mycoses

Country Status (4)

Country Link
US (1) US20140128468A1 (fr)
EP (1) EP2723326A1 (fr)
FR (1) FR2976806B1 (fr)
WO (1) WO2012175881A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3019552B1 (fr) * 2014-04-03 2016-04-01 Urgo Lab Composition filmogene
EP3478234A4 (fr) * 2016-06-29 2020-02-26 IVIEW Therapeutics, Inc. Nouvelles compositions de formation de couche mince à dépôt rapide en tant que traitement efficace de soin des plaies
JP7597558B2 (ja) * 2020-09-18 2024-12-10 久光製薬株式会社 皮膜形成型外用製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
DK1931309T3 (da) * 2005-09-29 2013-01-02 Novartis Ag Antimykotisk sammensætning
WO2009070736A1 (fr) * 2007-11-29 2009-06-04 Inolex Investment Corporation Conservateurs pour compositions cosmétiques, de toilette et pharmaceutiques

Also Published As

Publication number Publication date
US20140128468A1 (en) 2014-05-08
EP2723326A1 (fr) 2014-04-30
FR2976806A1 (fr) 2012-12-28
WO2012175881A1 (fr) 2012-12-27

Similar Documents

Publication Publication Date Title
EP2755676A4 (fr) Composition et pansement pour le traitement de blessures
EP2836482A4 (fr) Compositions et méthodes pour le traitement du cancer
EP2844346A4 (fr) Compositions pharmaceutiques pour traitement combiné
EP2906208A4 (fr) Traitement thérapeutique
EP2670434A4 (fr) Traitement de tauopathies
EP2818483A4 (fr) Composition médicinale pour le traitement et/ou la prévention du cancer
EP2920308A4 (fr) Traitement du cancer
EP2521913A4 (fr) Procédés et compositions pour le traitement du cancer
EP2830661A4 (fr) Méthodes et compositions diagnostiques pour le traitement du cancer
EP2688594A4 (fr) Procédés et compositions pour le traitement du cancer
EP2800579A4 (fr) Procédés et compositions pour le traitement du diabète
PL2830654T3 (pl) Sposoby i kompozycje do leczenia zapalenia
EP2914274A4 (fr) Probiotique modifié génétiquement pour le traitement de la phénylcétonurie
EP2632452A4 (fr) Composés et compositions pour le traitement du cancer
EP2807111A4 (fr) Nanomatériaux multifonctionnels pour le traitement du cancer
EP2921510A4 (fr) Composition de traitement de surface
EP2852571A4 (fr) Compositions et méthodes pour le traitement de la mucosite
EP2817011A4 (fr) Traitement du cancer
EP2897613A4 (fr) Compositions de traitement
EP2544692A4 (fr) Utilisation de la tigécycline pour le traitement du cancer
EP2919759A4 (fr) Matières et procédés utiles pour le traitement du glioblastome
EP2861302A4 (fr) Utilisation de modulateurs de ccr5 dans le traitement du cancer
FR20C1044I2 (fr) Triazines pour le traitement des infections protozoïques
EP2830644A4 (fr) Procédés et compositions pour la prévention et le traitement de la neuropathie
EP2863939A4 (fr) Compositions et procédés pour le traitement du vitiligo

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

ST Notification of lapse

Effective date: 20170228